Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-25 @ 2:32 AM
NCT ID:
NCT00036634
Eligibility Criteria:
Inclusion Criteria
* HIV-1 RNA levels greater than or equal to 30,000 copies/mL
* CD4 count greater than or equal to 200 cells/mm3
* Serum creatinine \<1.5 mg/dl
* Hepatic transaminases less than or equal to 2.5 times the upper limit of normal
* Total bilirubin less than or equal to 1.5 mg/dL
* Adequate hematologic function
* Serum amylase less than or equal to 1.5 times the upper limit of normal
* Serum phosphate greater than or equal to 2.2 mg/dL
* Not pregnant
Exclusion Criteria
* Prior treatment with antiretroviral therapy
* Immunization within 30 days of study entry
* A new AIDS defining condition within 30 days of study entry
* Receiving nephrotoxic agents, probenecid, chemotherapeutic agents, corticosteroids, interleukin-2
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00036634
Study Brief:
Protocol Section:
NCT00036634